ExodusPoint Capital Management’s Viking Therapeutics VKTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.03M | Sell |
38,716
-311,094
| -89% | -$8.24M | 0.01% | 897 |
|
|
2025
Q1 | $8.45M | Buy |
349,810
+114,307
| +49% | +$2.76M | 0.08% | 225 |
|
|
2024
Q4 | $9.48M | Sell |
235,503
-27,656
| -11% | -$1.11M | 0.07% | 255 |
|
|
2024
Q3 | $16.7M | Buy |
263,159
+210,229
| +397% | +$13.3M | 0.1% | 132 |
|
|
2024
Q2 | $2.81M | Buy |
52,930
+38,835
| +276% | +$2.06M | 0.02% | 552 |
|
|
2024
Q1 | $1.16M | Sell |
14,095
-53,734
| -79% | -$4.41M | 0.01% | 792 |
|
|
2023
Q4 | $1.26M | Buy |
+67,829
| New | +$1.26M | 0.01% | 679 |
|
|
2022
Q4 | – | Sell |
-30,753
| Closed | -$84K | – | 2102 |
|
|
2022
Q3 | $84K | Buy |
30,753
+6,512
| +27% | +$17.8K | ﹤0.01% | 1728 |
|
|
2022
Q2 | $70K | Buy |
+24,241
| New | +$70K | ﹤0.01% | 1723 |
|
|
2021
Q4 | – | Sell |
-24,405
| Closed | -$153K | – | 2564 |
|
|
2021
Q3 | $153K | Sell |
24,405
-51,235
| -68% | -$321K | ﹤0.01% | 1779 |
|
|
2021
Q2 | $453K | Buy |
75,640
+16,357
| +28% | +$98K | 0.01% | 1431 |
|
|
2021
Q1 | $375K | Buy |
+59,283
| New | +$375K | 0.01% | 1486 |
|
|
2020
Q3 | – | Sell |
-26,469
| Closed | -$191K | – | 2194 |
|
|
2020
Q2 | $191K | Buy |
+26,469
| New | +$191K | 0.01% | 1505 |
|
|
2020
Q1 | – | Sell |
-20,102
| Closed | -$161K | – | 1607 |
|
|
2019
Q4 | $161K | Sell |
20,102
-15,502
| -44% | -$124K | ﹤0.01% | 1322 |
|
|
2019
Q3 | $245K | Buy |
35,604
+17,966
| +102% | +$124K | 0.01% | 978 |
|
|
2019
Q2 | $146K | Buy |
+17,638
| New | +$146K | 0.01% | 958 |
|